
    
      Patients with a morphologically proven diagnosis AML and both the two following criteria:

        -  Age > 50 years and Â£ 70 years.

        -  Not previously treated for their disease.

      Randomization will be centralized by phone :

      Arm A chemotherapy with daunorubicin and Aracytine or Arm B Daunorubicin and Aracytine and
      Mylotarg.
    
  